tiprankstipranks
Trending News
More News >
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Advertisement

Galectin Therapeutics (GALT) Revenue

Compare
625 Followers

Galectin Therapeutics Revenue

Galectin Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 36.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Galectin Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
36.00K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
15
Market Cap
$240.23M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis